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ARTICLE
Competing protein-protein interactions regulate
binding of Hsp27 to its client protein tau
Rebecca Freilich1, Miguel Betegon2, Eric Tse2, Sue-Ann Mok 1, Olivier Julien 1, David A. Agard2,
Daniel R. Southworth2, Koh Takeuchi 3 & Jason E. Gestwicki 1
Small heat shock proteins (sHSPs) are a class of oligomeric molecular chaperones that limit
protein aggregation. However, it is often not clear where sHSPs bind on their client proteins
or how these protein-protein interactions (PPIs) are regulated. Here, we map the PPIs
between human Hsp27 and the microtubule-associated protein tau (MAPT/tau). We find
that Hsp27 selectively recognizes two aggregation-prone regions of tau, using the conserved
β4-β8 cleft of its alpha-crystallin domain. The β4-β8 region is also the site of Hsp27–Hsp27
interactions, suggesting that competitive PPIs may be an important regulatory paradigm.
Indeed, we find that each of the individual PPIs are relatively weak and that competition for
shared sites seems to control both client binding and Hsp27 oligomerization. These findings
highlight the importance of multiple, competitive PPIs in the function of Hsp27 and suggest
that the β4-β8 groove acts as a tunable sensor for clients.
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Molecular chaperones maintain cellular protein home-ostasis (proteostasis)1. Among these chaperones, thesmall heat shock proteins (sHSPs) play a key role by
preventing the aggregation of partially unfolded proteins2–4.
Specifically, sHSPs are thought to maintain their client proteins in
a soluble, folding-competent state for subsequent processing by
ATP-dependent chaperones5,6, such as Hsp70. In this way, the
sHSPs act as sentinels of protein unfolding, especially in response
to stress or conditions that would promote protein aggregation.
Hsp27 is a broadly expressed member of the sHSP family,
which prevents aggregation of a large number of putative clients7.
As a consequence of these interactions, Hsp27 has been impli-
cated in many diseases, including neurodegeneration8–10. Despite
its important roles, the molecular mechanisms of Hsp27 function
remain mysterious. Like all sHSPs, Hsp27 contains a highly
conserved α-crystallin domain (ACD) flanked by disordered N-
and C-terminal domains (NTD and CTD) (Fig. 1a). The ACD has
an anti-parallel β-sandwich fold and cross β-sheet interactions
between two of these domains mediate the dimerization of
sHSPs11,12. These dimers are then assembled into larger species
(up to ~30 mers) through a series of distinct PPIs that involve
different regions of the ACD, as well as the NTD and CTD. The
best characterized of these oligomer-stabilizing PPIs is the one
between IXI motifs in the CTD and the β4–β8 groove of the
ACD12–15. This interaction involves binding of the linear, dis-
ordered IXI motif into a shallow groove between β-sheets 4 and
8. The IXI interaction with β4–β8 is important in homo-oligomer
formation but it can also facilitate heterodimer formation
between different members of the sHSP family16. Separate PPIs
involving the NTD are also thought to contribute to oligomer
formation16–18, but the specific interaction sites are not known.
However, Hsp27’s NTD is clearly important because three
phosphorylation sites in that region regulate oligomer assembly19.
One of the major roles of Hsp27 is to prevent aggregation of its
client proteins. However, it is not yet clear where Hsp27 binds to
clients or how it stabilizes them. Work in other sHSPs, such as α-
crystallin20, yeast Hsp425, and plant Hsp1821–23 has suggested
that different surfaces can be used to engage clients. It has been
shown that the highly conserved ACD is sufficient to prevent
aggregation of certain clients12,20, while the NTD is necessary for
others20,24–27. However, the factors that determine what types of
clients are bound and what parts of Hsp27 are involved (i.e.,
ACD, NTD, and CTD) remain ambiguous. One of the key issues
is that the natural clients of the sHSPs are often not known.
Model proteins, such as firefly luciferase, citrate synthase and
malate dehydrogenase, have been used to study mechanisms of
sHSP function5,22,28, but biophysical information on native
interactions is sparse7,29,30.
In this study, we characterized the interactions between Hsp27
and microtubule-associated protein tau (MAPT/tau). We selected
tau for these studies because Hsp27 has been shown to regulate
tau’s aggregation in vitro and in vivo31,32, making it one of the
few well-validated, natural clients. Moreover, tau is an intrinsi-
cally disordered protein, a feature that removes the complication
of considering both folded and unfolded states. Finally, tau is
known to aggregate in a number of progressive, untreatable
neurodegenerative disorders33, including some forms of Alzhei-
mer’s disease (AD), so mechanistic information about how Hsp27
acts on it would be of biomedical interest. Indeed, overexpression
of Hsp27 has been found to be partially protective in animal
models of tauopathy31.
Using a combination of biophysical techniques, we characterize
Hsp27’s interactions with tau. We find that Hsp27 binds two sites
on tau (PHF6 and PHF6*) that are well known to be required for
aggregation. The location of these interactions helps explain the
strong anti-aggregation activity of Hsp27 and suggests that the
chaperone may be tuned to prefer the most problematic regions
in tau. On the other side, we find that Hsp27 uses both its NTD
and β4–β8 groove to bind tau. The involvement of the β4–β8
groove was unexpected and interesting because, as mentioned
above, this region is also known to bind IXI motifs within the
sHSP oligomer. Thus, this result suggests that competition
between client and IXI might limit chaperone function. Indeed,
we find that Hsp27–Hsp27 interactions, mediated by the IXI
motifs, seem to partially counteract tau binding. We speculate
that this set of competing PPIs may normally hold Hsp27 in a
latent, inactive oligomer prior to accumulation of sufficient levels
of misfolded client to overcome the self-limiting interactions.
Finally, we find that ACD binding alone is not sufficient to
prevent tau aggregation and that additional contacts in the NTD
are required. Together, these results suggest that, at least for tau,
Hsp27’s NTD plays a major role in chaperone function, while the
β4–β8 groove serves as an important client sensor. This model
advances our understanding of sHSP structure-function and
suggests potential ways of targeting Hsp27 for drug discovery.
Results
Hsp27’s β4/β8 groove is a PPI hot spot. Because the ACD has
been shown to have chaperone activity for some clients20, we first
measured the interaction of 15N-labeled Hsp27 ACD with tau by
HSQC NMR11. In this experiment, we utilized two isoforms of
tau (Fig. 1a and Supplementary Figure 1): the full-length splice
variant 0N4R tau, which is commonly expressed in adult brain
and K18, a construct containing just the four microtubule-
binding repeats (MTBRs) that is known to contain the binding
sites of other chaperones34,35. We found that both tau isoforms
caused chemical shift perturbations (CSPs; >0.4 ppm) within the
hydrophobic β4–β8 groove of the ACD, in addition to sporadic
shifts along the dimer interface (Fig. 1b). The β4–β8 groove is a
conserved binding site for IXI motifs14, as well as the Hsp70 co-
chaperone BAG336 and some other clients20. Moreover, a recent
study also suggested that tau binds to this region of Hsp27’s
ACD32. To better understand how tau and the IXI motif (which is
isoleucine, proline, valine (IPV) in Hsp27) might compete for the
same region, we first synthesized the 9-mer peptide of Hsp27
(176EITIPVTFE185) and confirmed its binding site in the HSQC
assay (Fig. 1c). We found that the peptide caused peak broad-
ening, indicating that it is in an intermediate exchange. As
expected, the affected peaks were localized to the β4–β8 groove,
confirming that both the IPV motif and tau bind the same region.
Next, we wanted to understand the relative affinity of the IPV
motif and tau protein for the β4–β8 groove. First, we used
isothermal calorimetry (ITC) to measure the affinity of Hsp27’s
IPV peptide for the β4–β8 groove in the purified Hsp27 ACD
(Fig. 1d and S2A). We found that the native Hsp27 IPV sequence
had a weak affinity for ACD (>25 µM). This weak affinity for the
isolated peptide made it difficult to identify the residues that
might contribute to affinity. Therefore, we swapped the
penultimate phenylalanine residue for a histidine (EITIPVTHE),
which is the identity of this position in the tighter binding motif
of the co-chaperone BAG3. As expected, this change improved
the affinity of the chimeric peptide to 11.5 ± 0.43 µM (see Fig. 1d).
Then, in the context of that His-containing sequence, we
examined the impact of mutating other residues that might
contribute to affinity using alanine scanning. In these studies, we
were particularly intrigued by the fact that Hsp27’s motif contains
an unusual, extended IXIXV sequence (ITIPV; see Fig. 1d).
However, alanine scanning revealed that the isoleucine (Ile179)
and valine (Val181) of the canonical IPV are the major
contributors to affinity; mutating either one of these residues
completely ablated the interaction (Kd > 25 µM). On the contrary,
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Fig. 1 Hsp27’s β4/β8 groove is a PPI hot spot for both client- and self-interactions. a Domain architecture of Hsp27 and Tau isoforms. b Left, HSQC spectra
of 15N Hsp27 ACD alone (150 µM, red) or in the presence of 250 µM K18 (blue). Right, chemical shift perturbations in ACD upon binding of 250 µM K18
(top) or 0N4R (bottom). c Left, intensity ratios upon binding of Hsp27 IPV peptide, with unassigned residues shown in gray. Right, HSQC spectra of 15N
Hsp27 ACD alone (150 µM, red) or in the presence of 250 µM Hsp27 IPV peptide (blue). d Isothermal calorimetry of Hsp27 ACD with IPV-derived
peptides. Left, representative ITC curve for Hsp27 IPV H peptide. Right, table of affinity values. ND, no detectable binding. Values are represented as mean
± standard error of the mean (SEM) determined from a minimum of three independent experiments. Bold letters highlight the mutated residue
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mutating either X residue in the IXIXV motif (EIATIPVTHE or
EITIAVTHE) modestly improved, rather than weakened, affinity
(Kd ~ 5 µM). The ITC titrations indicated that all of the peptides
have a binding stoichiometry of between 0.5 and 1, suggesting
that the peptides do not always occupy all available β4–β8
binding sites on the ACD dimer. Thus, from these experiments,
we concluded that the native IPV peptide of Hsp27 (EITIPVTFE)
has a weak affinity for the β4–β8 groove (>25 µM) and that Ile179
and Val181 are important for the interaction.
Given that the IPV peptide binds weakly, we wondered
whether tau might have a stronger affinity for the Hsp27 ACD.
However, we expected this interaction to be quite weak, because
of previous NMR titrations32 and, consistent with this idea, we
were unable to achieve saturable binding of K18 tau to Hsp27’s
ACD by a competitive ELISA (estimated IC50 > 100 µM; Supple-
mentary Figure 3A), Likewise, solubility prevented accurate
measurement of this affinity by ITC (Kd > 100 µM; Supplemen-
tary Figure 3B). Thus, we concluded that both IPV peptides and
tau bind at the β4–β8 groove with weak affinity.
Hsp27 binding to tau can be obscured by self-interactions.
Next, we wanted to study the other side of the interaction and
learn where Hsp27 binds on tau. Because our earlier study sug-
gested that K18 and 0N4R tau bind similarly to Hsp27’s ACD (see
Fig. 1), we focused on the shorter K18 region as likely to contain
the major site(s). Accordingly, we used 15N-labeled K18 in HSQC
NMR experiments to map putative interactions with unlabeled
Hsp27 ACD. We found that addition of Hsp27’s ACD caused
peak broadening in two remarkably discrete locations (Fig. 2).
These binding sites include the well documented PHF6
(275-VQIINK-280) and PHF6* (306-VQIVYK-311) regions, which
are known to be required for tau aggregation37. To confirm
whether the β4–β8 groove was involved in this binding,
we purified an Hsp27 ACD mutant, L157A. This residue was
previously identified as being important in IXI interactions14 and
we confirmed that mutation blocks binding to BAG3 (Supple-
mentary Figure 4). Surprisingly, we found that the L157A
mutation ablated the interaction with the first motif, but not the
second (Fig. 2), suggesting that the binding modes of the two
peptide regions may not be equivalent.
In order to study the two binding sites in more detail, we
carried out a titration analysis using a TROSY scheme with better
chemical shift resolution38. Titration of Hsp27 ACD into 15N-
labeled K18 tau confirmed that the main binding interaction
occurs at the two PHF6 and PHF6* motifs, with minor
interactions at residues 292–297 and 349–353 (Supplementary
Figure 5A). Consistent with the importance of these motifs,
deletion of residues 277 and 278 (K18 Δ277–278) in the middle of
VQIINK limited binding to PHF6, while deleting residues 308
and 309 (K18 Δ308–309) had the same effect as PHF6*
(Supplementary Figure 5B). Likewise, deleting both sets of
residues (K18 double mutant) entirely abolished the interaction
with Hsp27’s ACD. Consistent with the studies above, we found
that the affinity of Hsp27 ACD for K18 tau was weak and
unsaturable by NMR titrations (Supplementary Figure 3C).
Likewise, titration of the 6-mer PHF6* peptide (VQIVYK) was
unable to produce saturable chemical shift changes in the 1H–15N
ACD spectra (Supplementary Figure 3D), supporting the idea
that the isolated interactions are weak. Together, these studies
showed that Hsp27 ACD and tau interact using at least two
regions: the β4–β8 groove of the ACD and the PHF6 and PHF6*
motifs of tau.
The NTDs of sHSPs have also been implicated in recognition
of various model clients. To determine whether it is involved in
tau binding, we purified Hsp27’s NTD and tested its binding to
15N K18 by HSQC. This experiment revealed broadening in a
large number of residues across the K18 sequence (Fig. 2).
Compared to the discrete ACD interaction, the NTD contacts
seemed to involve multiple parts of K18 tau, including the PHF6
and PHF6* aggregation motifs, as well as broad regions
corresponding to residues 246–268 and 342–361.
The evidence so far suggested that Hsp27 interacts with tau
using both its ACD and NTD. We hypothesized, therefore, that
the full-length Hsp27 protein, containing both the NTD and the
ACD, might have tight affinity due to multivalent interactions.
However, when we tested binding of full-length Hsp27 to K18 tau
(Fig. 2 and Supplementary Figure 6), we observed no broadening
or CSPs. This result is consistent with an alternative model in
which the Hsp27–Hsp27 interactions, mediated by the IPV motifs
locking together with β4–β8 grooves in adjacent ACDs, largely
hides this PPI surface from interacting with tau. Indeed, previous
structural studies15 have shown that Hsp27’s IPV motifs engage
in extensive PPIs with itself in the context of large oligomers.
Based on these results, we speculate that the weaker interactions
of tau cannot, under these conditions at least, compete with
Hsp27’s IPV motifs in the context of larger oligomers. In other
words, although both tau and IPV peptide bind Hsp27’s ACD
weakly as isolated peptides (see Fig. 1), the high local
concentration of IPVs in an intact Hsp27 oligomer seems to
create an avidity effect that outcompetes binding to monomeric
tau. Moreover, our observations also suggest that even the NTDs
must be restricted from interacting with monomeric tau in the
context of full-length Hsp27. We conclude that the NTDs, which
bind to tau in isolation, are somehow masked in the context of
Hsp27 oligomers (see below).
Hsp27’s NTD plays a functional role in chaperoning tau. So
then, how does Hsp27 become activated as a chaperone? To
explore this question, we first focused on the phosphorylations of
the NTD because these have been shown to reduce oligomer size
and increase chaperone activity in other systems19,24. Thus, we
reasoned that phosphorylation of the NTD might partially release
its availability for binding to tau. This activation might occur
through multiple mechanisms: (a) increasing the availability of
unoccupied β4–β8 grooves by reducing oligomer size and freeing
the self-IPV motifs and/or (b) increasing the display of available
NTDs.
To explore these ideas, we first measured the ability of Hsp27
to suppress aggregation of tau in vitro, as measured by thioflavin
T (ThT) fluorescence. Here, we used the suppression of tau
aggregation as a model chaperone function. Before starting these
studies, we first confirmed previous observations31 that full-
length Hsp27 prevents aggregation of both 0N4R and K18 in the
ThT assay (Fig. 3a), significantly increasing the lag time and
slowing the elongation rate. The chaperone also sometimes
produced an increase in the apparent maximal level of
fluorescence signal, which may occur because it is partially
incorporated into the insoluble fraction (Supplementary Figure 7).
Why can WT Hsp27 suppress tau aggregation if its IPV motifs
are already engaged in self-interactions? Presumably, Hsp27’s
ACDs and NTDs bind to tau under these conditions because the
high local concentration of the client, in the context of a growing
fibril or earlier intermediate32, outcompetes the self-limiting
contacts. Although this possibility is difficult to directly measure,
this idea could provide a way for the chaperone to remain off
until clients become damaged.
Using the ThT assay, we next explored the roles of NTD and its
phosphorylation. We found that deletion of the NTD (ΔNTD)
ablated Hsp27’s ability to delay tau aggregation, showing that this
region is essential to chaperone function. Consistent with this
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result, the ACD alone had no effect on tau aggregation, despite
the fact that it would be predicted to (weakly) bind to the PHF6
and PHF6* motifs. The ACD is known to have chaperone activity
in other amyloid-prone client systems20, but it does not seem to
be sufficient for tau.
Then, we explored the effect of NTD phosphorylation on
binding to tau. Specifically, we used a pseudo-phosphorylation
mutant, termed 3D, in which three key serine residues (S15, S78,
and S82) are replaced with aspartate as a phospho-isostere31. We
first confirmed that oligomers of Hsp27 3D are more hetero-
geneous and generally smaller than oligomers of WT Hsp27, as
measured by negative-stain EM and SEC-MALS (Fig. 3b), but
with roughly equivalent melting temperature (Supplementary
Figure 8A). In both the intensity-based HSQC (Fig. 3c) and the
chemical shift-based, TROSY-HSQC (Supplementary Figure 6)
platforms, we found that Hsp27 3D binds to K18’s aggregation
motifs (PHF6 and PHF6*), while WT does not. Also, we found
that Hsp27 3D retains the ability to prevent tau aggregation by
ThT assays (Fig. 3d), although we were not able to confidently
determine whether WT or 3D Hsp27 were the superior
chaperone (Supplementary Figure 7). Together, these results
suggest that reducing oligomer size, through pseudo-
phosphorylation of the NTD, partially releases the internal, self-
limiting PPIs and activates tau binding and anti-aggregation
activity.
The β4/β8 groove regulates sHSP oligomerization and func-
tion. These results suggest a model in which the NTD is a major
domain for chaperone function, at least for tau, while the β4–β8
groove of the ACD is a hot spot for regulatory PPIs. To further
explore the role of the β4–β8 groove as a sensor, we wondered
what effect weakening the self IPV–ACD interactions might have.
Based on the alanine scanning and recent work32, we mutated the
isoleucine and valine residues in the IPV to glycine (Hsp27 GPG).
Hsp27 GPG has an altered oligomeric structure as compared to
WT (Supplementary Figure 8B) and, as expected, it has a lower
apparent melting temperature, as measured by differential scan-
ning fluorimetry (DSF) (Fig. 4a).
To understand whether the Hsp27 GPG mutant created
additional opportunities for tau binding in the β4/β8 grooves,
we first measured its affinity for IPV peptides by ITC
(Supplementary Figure 2B). In this experiment, we again used
the His-containing IPV peptides as a surrogate for binding site
availability because they have tighter affinity than tau or the
native sequence, so are more accurate to measure. As expected,
we found that WT Hsp27 does not bind IPV peptide
(EITIPVTHE; Fig. 4b), likely due to the high occupancy of the
β4–β8 grooves. However, Hsp27 GPG bound to IPV with an
affinity of ~10 µM, similar to that of an isolated ACD (see
Fig. 1d). This result suggests that easing the internal competition
can, indeed, partially expose β4–β8 grooves and promote binding
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to client. However, Hsp27 GPG had a reduced binding
stoichiometry (n= 0.2), indicating that not all β4–β8 grooves
are available. To further probe the role of oligomeric interactions
in the availability of β4/β8 grooves, we deleted the NTD from
Hsp27 WT (ΔNTD) and Hsp27 GPG (ΔNTD GPG). These
proteins were intended to release the NTD contacts entirely and
create smaller oligomers. Indeed, the ΔNTD GPG construct is a
dimer (Supplementary Figure 8C), consistent with the partial loss
of both the NTD and IPV contacts. However, ΔNTD results in a
heterogeneous mixture of 3–5 mers (Supplementary Figure 8C),
likely because of the residual IPV–ACD contacts. Despite these
slight differences, both ΔNTD and ΔNTD GPG had similar
affinities for the IPV peptide (EITIPVTHE; 11.4 and 14.3 µM,
respectively). Thus, one model to explain this result is that more
β4–β8 grooves may be available for binding in the absence of
NTD. Finally, we wondered whether Hsp27 3D would contain a
greater number of free β4/β8 grooves because of its smaller
oligomeric size. However, Hsp27 3D bound poorly to the
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His-containing IPV peptide (Kd > 50 µM), suggesting that there is
still sufficient β4/β8 groove occupancy in this oligomer to exclude
peptide. Thus, the number of available β4–β8 grooves seems to be
a product of both internal competition for IPV motifs, as well as
less well understood contributions from relative oligomer size and
avidity effects.
After using the IPV peptides as a surrogate for available tau
binding sites, we confirmed that Hsp27 GPG could interact with
K18 tau by NMR. We found that Hsp27 GPG bound to K18 by
both the intensity- and chemical shift-based NMR (Fig. 4c and
Supplementary Figure 6), further highlighting the importance of
competition between client and self in Hsp27.
Dynamic PPIs are important for anti-aggregation activity.
These studies suggested that a series of competitive PPIs, driven
by self- and client-interactions, as well as changes in phosphor-
ylation and oligomerization, might coordinate Hsp27 function.
This concept is in agreement with results from cryo-EM, mass
spectrometry and SAXS studies of related systems, suggesting the
importance of dynamics in sHSP oligomers39–42 and sHSP-client
interactions23,28. While it is difficult to accurately measure
changes in Hsp27-tau dynamics during a chaperone cycle, we
decided to cross-link Hsp27 and ask what effect this chemical
modification would have on its ability to suppress tau aggrega-
tion. Specifically, we treated WT Hsp27 with gluteraldehyde and
selected a concentration of crosslinker that would produce
samples with a similar oligomeric size to the untreated protein
by SEC-MALS (Fig. 5a, Supplementary Figure 8D). Consistent
with a role for dynamics, we found that the cross-linked sample
(Hsp27 X) was severely compromised in suppressing aggregation
of 0N4R or K18 tau (Fig. 5b). Although further work is needed,
this finding is supportive of the idea that shifting PPIs regulate
sHSP function.
Discussion
Previous work had shown that the ACD alone is sufficient to bind
some clients but not others12,20,43, suggesting that sHSPs may use
different binding sites depending on the type of client. Here, we
focused on mapping the interactions of Hsp27 with its native
client, tau, which is important in AD and other neurodegenera-
tive tauopathies33. We found that both the NTD and ACD of
Hsp27 bind to the PHF6 and PHF6* aggregation motifs of tau,
but that the accessibility of Hsp27’s binding surfaces are limited
in the full-length protein by self-interactions within the oligomer.
Importantly, each of these individual PPIs was determined to be
relatively weak in isolation (>25 to >100 µM). However, avidity
effects at high local concentration, such as when tau begins to
aggregate (see Fig. 3), seems to tune these relative binding
affinities.
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Based on these results and the pioneering work of oth-
ers19,20,22,24,44, we propose a parsimonious model for Hsp27
function (Fig. 6): in its resting state Hsp27’s β4/β8 groove is
occupied by its own IPV motifs and it may be further auto-
inhibited by additional oligomeric interactions with the NTDs.
We speculate that these self-limiting PPIs are important to pre-
clude client binding that might be detrimental to folding under
normal, healthy conditions. However, under conditions of stress,
the presence of higher affinity co-chaperones (e.g., BAG3)36 and/
or a large excess of clients (e.g., aggregating tau) is proposed to
compete for even these multivalent PPIs. The activation of Hsp27
is likely further amplified by stress-responsive phosphorylation of
the NTD, which further de-oligomerizes the complex and helps to
reveal both NTDs and some β4–β8 grooves (see Fig. 4). The result
of these shifting PPI priorities is that client binding in now
favored. At the end of the cycle, we speculate that this same
competing set of interactions might also serve to facilitate Hsp27
release from clients. In other words, as the levels of stress-
responsive phosphorylation diminish and the levels of damaged
client drop, the internal IPV–ACD contacts might help restore
Hsp27 to its storage state. The reversibility of this regulatory step
might be particularly important for sHSPs, because they lack the
ATPase activity that other chaperones, such as Hsp70, use to
promote cycles of client release. In this way, the sHSPs might
have more in common with non-enzymatic chaperones such as
trigger factor45 and Spy46, which use dynamic, competitive PPIs
to generate reversibility.
There is great interest in either activating Hsp27 for the
treatment of tauopathies31 or inhibiting Hsp27 for the potential
treatment of cancer47 or cystic fibrosis48. Thus, it seems worth
evaluating the implications of this model for translational
research. This is especially true because Hsp27’s lack of enzymatic
activity implies that its PPIs may be the best sites for chemical
perturbation49. Our findings here suggest that both the NTD and
ACD contain potential sites for drug discovery.
We found that the β4/β8 groove of Hsp27 is an unexpected
nexus for PPIs; a number of partners, including itself, clients, and
co-chaperones (e.g., BAG3) bind the same region. While the
number of binding partners for this site highlights its functional
importance, it also creates a challenge for targeting the β4–β8
groove with small molecules. For example, compounds that bind
this region might be counter-productive in some neurodegen-
erative disease settings because they would be expected to com-
pete for the client themselves. At the same time, such compounds
might partially release the self-limiting IPV–ACD contacts and,
potentially, reveal the NTDs. Thus, we anticipate that molecules
targeting the β4–β8 groove could be either activators or inhibitors
of Hsp27 activity, depending on occupancy of the site and con-
centration/identity of binding partners.
Alternatively, the NTD could be a potential site for chemical
intervention. This region seemed to be essential in chaperone
function, at least for tau, while also playing a role in Hsp27
oligomerization. However, due to the lack of structural knowledge
about this disordered region, it will likely be difficult to find a
molecule that selectively interacts with it. Rather, manipulation of
the NTD might be best achieved through controlling the stress
pathways that tune posttranslational modifications.
Due to the conceptual difficulty in targeting either the NTD or
β4–β8 groove directly, we propose that targeting the dynamics of
Hsp27 may be a more fruitful approach. For example, one
might stabilize specific PPIs to trap the chaperone in a specific
state, favoring either client retention or release. In neurodegen-
eration or cancer, one might want to trap distinct states. For
example, our work suggests that trapping the tau-bound Hsp27
complex might be a good way to limit tau aggregation. Thus,
more broadly understanding how natural clients, in addition to
tau, bind to Hsp27 and other sHSPs will likely be an important
next step.
Methods
Cloning and recombinant protein purification. Vectors for the expression of full-
length human Hsp27 and Hsp27 ACD (residues Q80–S176) were a gift from the
Klevit laboratory (University of Washington), and proteins were expressed and
purified as described50. Hsp27 ACD L157A was generated using standard site-
directed mutagenesis protocols (Supplementary Table 1). The vector for expression
of Hsp27 3D was a gift from the Dickey laboratory (University of South Florida)
and the protein was expressed and purified as described31. The Hsp27 NTD
truncation, encompassing residues 1–88, was subcloned into a CMX3 vector
using XhoI and Nde1 restriction enzymes. For all other Hsp27 constructs (GPG,
ΔNTD consisting of residues 80–205), coding sequences were optimized for
Escherichia coli, purchased from Integrated DNA Technologies, and LIC cloned
into a PMCSG7 vector. All constructs were transformed in E. coli BL21 (DE3) cells,
grown to an OD600 of 0.6 in Terrific Broth (TB), and induced with 0.5 mM IPTG
overnight at 18 °C. Cells were pelleted and re-suspended in 50 mM Tris-HCl
pH 8.0, 10 mM imidazole, 500 mM NaCl and lysed by sonication. The cleared
lysate was applied Ni-NTA resin (Qiagen) and eluted with buffer containing
300 mM imidazole. Proteins were concentrated and further purified by size
exclusion on a Superdex 200 16/600 column (GE Healthcare) equilibrated with
SEC buffer (50 mM sodium phosphate pH 7.5, 100 mM NaCl). Tau constructs,
human 0N4R and unlabeled and 15N-labeled K18 were purified from E. coli BL21
(DE3)34. Briefly, sodium chloride (500 mM) and betaine (10 mM), were included in
the TB prior to induction. Expression was induced with 200 µM IPTG for 3.5 h at
30 °C. Cells were lysed via a microfluidizer (Microfluidics) followed by boiling of
lysate for 20 min. The clarified supernatant was then dialyzed overnight (buffer A:
20 mMMES pH 6.8, 50 mM NaCl, 1 mM EGTA, 1 mMMgCl, 2 mM DTT, 0.1 mM
PMSF) and purified by cation exchange with a pre-elution step of 15% elution
buffer (4 column volumes of buffer A with 1 M NaCl). Following a 15–60% gra-
dient elution, pure tau fractions were pooled and concentrated prior to snap
freezing aliquots for storage at −80 °C. For NMR experiments, tau was purified
as above except that cells were grown in M9 minimal media containing 15NH4Cl
(1 g/L) and 1% glycerol. Purified 15N-labeled tau was dialyzed overnight into 20
mM ammonium bicarbonate solution then lyophilized and stored at 4 °C. All
peptides were purchased from Genescript.
NMR spectroscopy. For Hsp27 ACD HSQC NMR experiments, all proteins were
dialyzed into SEC buffer (50 mM sodium phosphate, 100 mM NaCl, pH 7.4). Then,
samples containing 150 µM ACD and either 0N4R or K18 tau were prepared. Two-
dimensional (2D) 1H–15N hetero-nuclear single quantum coherence (HSQC)
spectra were required at 32 °C on a Bruker Avance III 500MHz spectrometer
equipped with a triple resonance, z-axis gradient probe. 256 scans were acquired
per t1 value for a total of 200 t1s. Spectral widths of 6009 Hz and 1419 Hz were
used in the 1H and 15N dimensions, respectively. Spectra were processed with
NMRPipe and analyzed in Sparky. Chemical shift perturbations were calculated
using the following equation,
CSP ¼ p ΔHð Þ2þ ΔN=5ð Þ2  ð1Þ
For 15N K18 HSQC NMR experiments, all proteins were dialyzed overnight
into NMR buffer (25 mM HEPES pH 7.4, 10 mM KCl, 5 mM MgCl2, 1 mM TCEP,
10% (v/v) D2O). Then, samples containing 50 μM 15N-labeled tau and 50 or
100 μM unlabeled chaperone in NMR buffer were prepared. 2D HSQC spectra
were acquired at 10 °C on a Bruker Avance AV800 spectrometer equipped with a
cryoprobe. 16 scans were acquired per t1 value and spectral widths of 2100 Hz and
10,416 Hz were used in the 1H and 15N dimensions, respectively. Spectra were
processed using rNMR and Sparky based on deposited tau assignments (Barre
2013, BioMagResBank accession number 19253). Signal intensity ratios were
calculated using Prism, by dividing the intensity of chaperone-bound peaks by
intensity of the same peak in the unbound spectra.
The 15N TROSY HSQC experiments were performed on a Bruker Avance
800MHz spectrometer equipped with the TXO cryogenic probe at 283 K. The
[U-15N] K18 proteins were dissolved at a concentration of 0.05–0.15 mM in 25mM
Hepes, 10 mM KCl, 5 mM MgCl2, 1 mM TCEP at pH 7.0 and titrated with the
Hsp27 proteins in the same buffer. The K18:Hsp27 molar ratios in the samples are
indicated in the figure legends. The 1H–15N TROSY HSQC experiments were
performed with 2048 direct (1H) and 512 indirect (15N) points with the spectral
width of 16 ppm and 36 ppm, respectively. All NMR spectra were processed by
Topspin 3.1, and analyzed with Sparky (Goddard and Kneller, SPARKY 3-NMR
Assignment and Integration Software. University of California, San Francisco, CA).
Tau aggregation assay. Aggregation assays were performed as previously
described34. Briefly, all proteins were dialyzed overnight at 4 °C into assay buffer
(Dulbecco’s PBS pH7.4, 2 mM MgCl2, 1 mM DTT). 0N4R or K18 Tau (10 μM)
was pre-incubated in the presence/absence of chaperones (5–20 μM) for 30 min at
37 °C. Thioflavin T (Sigma) at a final concentration of 10 μM was added and
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aggregation was induced by the addition of a freshly prepared heparin sodium salt
solution (Santa Cruz) at a final concentration of 44 µg/mL. For non-induced
controls, assay buffer was added in place of heparin solution. The aggregation
reaction was carried out at 37 °C with continuous shaking and monitored via
Thioflavin T fluorescence (excitation= 444 nm, emission= 485 nm, cutoff= 480
nm) in a Spectramax M5 microplate reader (Molecular Devices). Readings were
taken every 5 min for a minimum of 24 h. Baseline curves of non-induced controls
(three replicates) were subtracted from induced samples (three replicates).
Electron microscopy. Samples of Hsp27 (1 µM, in SEC buffer) were negatively
stained with uranyl formate (pH ~6.0) on thin-carbon layered 400-mesh copper
grids (Ted Pella) that were glow discharged before sample was applied. Samples
were imaged using a Tecnai T12 Spirit TEM (FEI) operated at 120 keV. Micro-
graph images were acquired with ∼1.5-µm defocus on a 4k × 4k CCD camera
(Gatan) at a magnification of 67,000× with a pixel size of 1.73 Å.
SEC-MALS. Solutions of Hsp27 were resolved by analytical SEC on a Shodex 804
column on an Ettan LC (GE Healthcare). Molecular weights were determined by
multi-angle laser light scattering using an in-line DAWN HELEOS detector and an
Optilab rEX differential refractive index detector (Wyatt Technology Corporation).
The column was equilibrated overnight in SEC buffer. Samples were analyzed at
the indicated concentrations. Calculation of molecular weights was performed
using the ASTRA software package (Wyatt Technology Corporation).
Isothermal titration calorimetry. For experiments with BAG3, proteins were
dialyzed overnight against ITC buffer (25 mM Hepes, 5 mM MgCl2, 100 mM KCl,
pH 7.5). For experiments with peptides, sHSPs were dialyzed overnight against
SEC buffer, and peptides were dissolved in dialysis buffer. Concentrations were
determined using BCA assays (Thermo Scientific), and the ITC experiment was
performed with a MicroCal ITC200 (GE Healthcare) at 25 °C. In BAG3 experi-
ments, sHSP (200 µM) in the syringe was titrated into a 10 μM cell solution of
BAG3 protein. For peptide binding experiments, peptide (1 mM) was titrated into a
cell containing Hsp27 proteins (100 µM). Calorimetric parameters were calculated
using Origin® 7.0 software and fit with a one-site binding model.
Thermal shift assay. Samples of Hsp27 (25 µL; 0.3 mg/mL) in DSF buffer (50 mM
NaPi pH 7.4, 700 mM NaCl, 50 mM LiCl) with a 5× final concentration of SYPRO
Orange (Sigma) were placed into a white 96-well plate with optically clear caps.
Melt curves were acquired on a Stratagene Mx300P RT-PCR using the SYPRO
filter set. Samples were heated from 25 to 95 °C in 1 °C increments for 2 min,
cooled to 25 °C at each cycle, and fluorescence was measured. The melting tem-
perature was determined using a Boltzmann fit in Prism.
Crosslinking of Hsp27. Samples of Hsp27 in SEC buffer (20 µM) were cross-
linked in the presence of 0.04% gluteraldehyde for 20 min, followed by quenching
with 2M Tris pH 7.4. Samples were dialyzed into SEC buffer post crosslinking.
Data availability
Data supporting the findings of this manuscript are available from the corresponding
author upon reasonable request.
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